Trial intelligence / Profile preview

Alprostadil Cream with WC3036 in Erectile Dysfunction

NCT01810575Phase 2Terminated

Sponsor
Warner Chilcott
Start
Feb 2013
Primary completion
Apr 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Vasostenoon in erectile dysfunction (ED), sponsored by Warner Chilcott. Started Feb 2013; status: terminated.

02

Drugs

Vasostenoon
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on NCT01810575.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01810575.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call